LAB CapEx to Revenue

Standard Biotools Inc · CapEx to Revenue

LAB logo

LAB CapEx to Revenue

Current (TTM)2.69%
LAB CapEx/Revenue (45.83% → 2.69%)
High-resolution chart · PNG

LAB capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Standard Biotools Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
9.7303%
4.7898%
2.6622%
3.9051%
10.1577%
9.2056%
2.1588%
0.3293%
1.5853%
4.8494%
9.2859%
6.3569%
6.583%
4.5554%
3.9099%
4.5858%
3.1442%
5.9295%
13.3746%
45.8268%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.